SCHEMBL30736409

SCHEMBL30736409

NC1CC(=O)N(N2Cc3ccccc3C2=O)C(=O)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.61
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
RNASEH1 O60930 1/20 0.42
PKM P14618 3/20 0.39
GAA P10253 2/20 0.37
TLR9 Q9NR96 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALOX15 P16050 2/20 0.37
TSHR P16473 2/20 0.37
SIRT1 Q96EB6 1/20 0.37
CRBN Q96SW2 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
APAF1 O14727 2/20 0.36
MAPT P10636 2/20 0.36
CASP1 P29466 1/20 0.36
BLM P54132 1/20 0.36
CASP7 P55210 1/20 0.36
XIAP P98170 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29569183 0.79 KMT2A (0.67) KMT2ARAB9ANPC1RNASEH1PKM
SCHEMBL23832541 0.79 KMT2A (0.67) KMT2ARAB9ANPC1RNASEH1PKM
Hydrochloric Acid SCHEMBL4557636 0.78 KMT2A (0.65) KMT2ARAB9ANPC1RNASEH1PKM
Diftalone SCHEMBL35351 0.77 KMT2A (1.00) KMT2ARAB9ANPC1RNASEH1PKM
Diftalone SCHEMBL29644941 0.77 KMT2A (1.00) KMT2ARAB9ANPC1RNASEH1PKM
SCHEMBL28411858 0.77 KMT2A (0.54) KMT2ARAB9ANPC1RNASEH1PKM
Formic Acid SCHEMBL38654533 0.73 KMT2A (0.57) KMT2ARAB9ANPC1RNASEH1PKM
SCHEMBL31352634 0.71 KMT2A (0.59) KMT2ARAB9ANPC1RNASEH1PKM
SCHEMBL28840917 0.71 KMT2A (0.59) KMT2ARAB9ANPC1RNASEH1PKM
SCHEMBL31019490 0.70 KMT2A (0.63) KMT2ARAB9ANPC1RNASEH1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230355759-A1 POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CLEAVAGE RESISTANT CD16 CELULARITY INC. (US) 2023-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230355759-A1 POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CLEAVAGE RESISTANT CD16 PBK, KLKB1, PIGK KMT2A 1363/4885RAB9A 4294/4885NPC1 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.